Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

BCG combined with mitomycin offers improved adjuvant treatment regimen for high...

Prof Dickon Hayne - University of Western Australia, Perth, Australia

BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC ( Prof Dickon Hayne - University of Western Australia, Perth, Australia )

Characteristics associated with longer-term OS with NALIRIFOX regimen in...

Dr Vincent Chung - City of Hope, Duarte, USA

Characteristics associated with longer-term OS with NALIRIFOX regimen in metastatic pancreatic adenocarcinoma ( Dr Vincent Chung - City of Hope, Duarte, USA )

Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

Dr Sara K Char - Dana-Farber Cancer Institute, Boston, USA

Pro-inflammatory diets associated with worse outcomes for stage III colon cancer ( Dr Sara K Char - Dana-Farber Cancer Institute, Boston, USA )

Exercise programme may lower risk of recurrence and death for some colon cancer...

Dr Christopher Booth - Queen's University, Kingston, Canada

Exercise programme may lower risk of recurrence and death for some colon cancer survivors ( Dr Christopher Booth - Queen's University, Kingston, Canada )

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received...

Prof Thomas Powles - Barts Cancer Institute, London, England

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab ( Prof Thomas Powles - Barts Cancer Institute, London, England )

Sasanlimab BCG combo improves outcomes in high-risk NMIBC

Prof Thomas Powles - Barts Cancer Institute, London, England

Sasanlimab BCG combo improves outcomes in high-risk NMIBC ( Prof Thomas Powles - Barts Cancer Institute, London, England )

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2...

Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC ( Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea )

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma ( Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours...

Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery ( Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA )

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy...

Dr Lajos Pusztai - Yale School of Medicine, New Haven, USA

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise ( Dr Lajos Pusztai - Yale School of Medicine, New Haven, USA )

Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers

Dr Erika P Hamilton - Sarah Cannon Research Institute, Nashville, USA

Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers ( Dr Erika P Hamilton - Sarah Cannon Research Institute, Nashville, USA )

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Dr Jean Abraham - University of Cambridge, Cambridge, UK

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )

More from ecancer